+33 1 76 70 47 90
/
creativ@creativ-ceutical.com
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
Relative efficacy and acceptability of vortioxetine versus marketed antidepressants
Home
Publications
Relative efficacy and acceptability of vortioxetine versus marketed antidepressants
Back Home
Relative efficacy and acceptability of vortioxetine versus marketed antidepressants
2013 ISPOR Europe
Llorca, P. M. | Lancon, C. | Brignone, M. | Rive, B. | Samir, S. | Francois, C. |
Volume: , Issue: , Pages: ,
https://www.doi.org/10.1016/j.jval.2013.08.1379
The website uses cookies.
Learn More
Ok
